Physicswallah Q4 FY26 Net Loss Narrows Sharply to 13176 Crore Revenue Jumps YearonYear SP 500 Edges Higher Led by Healthcare and Technology Gains Meta Shares Fall After Earnings Report Internet Disruptions in Iran Weigh on User Metrics SpaceXs Potential SP Sector Classification Analysing the Options for the Private Space Giant Trump Expresses Dissatisfaction with Iran Nuclear Deal Talks Heightening Geopolitical Uncertainty Bank of America Adjusts Apple Price Target Amid Artificial Intelligence Developments Lifeway Foods Inc LWAY Q1 2026 Earnings EPS Slightly Misses Estimates Amid Modest Stock Advance Phillips 66 Q1 2026 Earnings Surprising Profit Amid a Challenging Macro Environment Grace Therapeutics Q1 2026 Earnings EPS Surprise of 5098 Despite No Revenue as Stock Declines MOLN Q4 2025 Earnings Positive EPS Surprise Highlights Cost Discipline Amid Clinical Progress Asbury Automotive Group Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction TXO Partners LP Q1 2026 Earnings Deep Loss Per Unit Fails to Deter Investors Stock Gains 393 Faraday Future Warrant FFAIW Continues Slide Trading Near AllTime Lows at 001 Silence Therapeutics SLN Gains 226 as Shares Approach Key Resistance at 713 CNX Resources Holds Near Support After Modest Decline Oncolytics Biotech ONCY Gains 247 as Shares Approach Key Resistance at 085 LightInTheBox LITB Surges 48 Testing Key Resistance at 275 as Volume Picks Up SWAG Q1 2026 Earnings Positive EPS Amid Limited Disclosure OTLY Q1 2026 Earnings Wider Loss Narrower Than Feared Stock Edges Higher AFYA Q1 2026 Earnings EPS Miss Weighs on Shares Despite Solid Operational Progress SLDB Q1 2026 Earnings WiderthanExpected Loss as Solid Biosciences Advances Gene Therapy Pipeline Aurora Innovation Q1 2026 Earnings EPS Beat Masks PreRevenue Reality Amid Ongoing Development Costs ADP Private Payrolls Top Expectations in April Signaling Stable Labor Market ALOY Q1 2024 Earnings EPS Misses Expectations as Company Reports Loss Flowco Holdings FLOC Slides Slightly Maintains Position Above Critical Support SOPA Q3 2025 Earnings Significant EPS Miss Raises Concerns about Profitability Reviva Pharmaceuticals RVPH Q1 2026 Earnings EPS Beats Estimates as Cost Discipline Drives SmallerThanExpected Loss SMMT Q1 2026 Earnings EPS Misses Street Expectations While Pipeline Momentum Continues Energy Transfer ET Q1 2026 Earnings EPS Miss Slightly Shares Edge Higher Amid Operational Strength UMBFO Q1 2026 Earnings Preferred Stock Performance Strong as EPS Surpasses Estimates by 1728 Autolus Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline SBC Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines